SCM
Silverarc Capital Management Portfolio holdings
AUM
$489M
This Quarter Return
+36.98%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$290M
AUM Growth
+$290M
(+23%)
Cap. Flow
+$29.5M
Cap. Flow
% of AUM
10.15%
Top 10 Holdings %
Top 10 Hldgs %
36.73%
Holding
98
New
24
Increased
37
Reduced
19
Closed
12
Top Buys
| 1 |
Madrigal Pharmaceuticals
MDGL
|
$14.5M |
| 2 |
Nuvalent
NUVL
|
$7.79M |
| 3 |
Terns Pharmaceuticals
TERN
|
$6.98M |
| 4 |
Biogen
BIIB
|
$6.09M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$5.5M |
Top Sells
| 1 |
Veracyte
VCYT
|
$11.1M |
| 2 |
Akero Therapeutics
AKRO
|
$7.01M |
| 3 |
APEN
Apollo Endosurgery, Inc.
APEN
|
$6.26M |
| 4 |
Cogent Biosciences
COGT
|
$4.94M |
| 5 |
Nkarta
NKTX
|
$4.77M |
Sector Composition
| 1 | Healthcare | 96.19% |
| 2 | Technology | 0.09% |
| 3 | Consumer Staples | 0% |
